Calcium-sensitive receptors influence pulmonary vascular remodeling in neonatal mice with persistent pulmonary hypertension

doi:10.12307/2022.539

Abstract

Abstract: BACKGROUND: Previous studies have shown the up-regulated expression of calcium-sensitive receptors in the neonatal mouse model of persistent pulmonary hypertension. The up-regulation trend is more obvious in the calcium-sensitive receptor agonist group, while the expression is declined somewhat in the calcium-sensitive receptor inhibitor group.
OBJECTIVE: To explore the mechanism of calcium-sensitive receptors in pulmonary remodeling in neonatal mice with hypoxia-induced persistent pulmonary hypertension.
METHODS: Eighty newborn C57BL/6 mice were randomly divided into four groups. Mice in the hypoxic group, the hypoxic+agonist group (hereinafter referred to as agonist group), and the hypoxic+antagonist group (hereinafter referred to as antagonist group) were placed in a hypoxic chamber simultaneously (oxygen concentration 12%). In addition, the agonist and antagonist groups were given intraperitoneal injection of calcium-sensitive receptor agonist GdCl3 (16 mg/kg) and inhibitor NPS2390 (1 mg/kg) once a day respectively. Mice in the normoxia group were exposed to air and injected with the same amount of normal saline daily as that in the hypoxic group. After 14 days, heart and lung tissues were removed. The thickness of ventricular wall and pulmonary vascular wall was measured and alveolar morphology was observed. The level of B-type brain natriuretic peptide was determined by enzyme linked immunosorbent assay. Western blot and immunohistochemistry were used to detect the expression and localization of caveolin-1 protein in mouse lung tissue, and qRT-PCR was used to detect the expression of caveolin-1 mRNA. The study protocol was approved by the Experimental Animal Ethic Committee of the First Affiliated Hospital of Shihezi University School of Medicine (approval No. 2018-172-01).
RESULTS AND CONCLUSION: After 14 days of hypoxia, the wall thickness of small pulmonary arterioles in mice increased, and the thickness ratio of right ventricle to left ventricle and B-type brain natriuretic peptide level increased in the hypoxic group compared with the normoxia group. The average alveolar lining interval was widened and the radial alveolar count decreased in the hypoxic group compared with the normoxia group. Western blot and qRT-PCR results showed that the expression levels of caveolin-1 protein and mRNA were up-regulated hypoxic group compared with the normoxia group (P < 0.05). These changes were more significant in the agonist group (P < 0.05), while the inhibitor group reversed the changes caused by hypoxia (P < 0.05). To conclude, calcium-sensitive receptor affects the vascular remodeling in the lung of neonatal mice with persistent pulmonary hypertension, and the mechanism may be related to the changes in the caveolin-1 expression.

Key words: caveolin-1, calcium-sensitive receptor, vascular remodeling, persistent pulmonary hypertension, mouse

CLC Number:

Zhu Yaping, Li Xiang, Chen Zhiwen, Liu Ying, Zhao Wenzhuo, Ma Ketao, Gu Qiang. Calcium-sensitive receptors influence pulmonary vascular remodeling in neonatal mice with persistent pulmonary hypertension[J]. Chinese Journal of Tissue Engineering Research, 2022, 26(17): 2708-2712.

Figures/Tables 6

References

[1] WANG M, ZHUANG D, MEI M, et al. Frequent mutation of hypoxia-related genes in persistent pulmonary hypertension of the newborn. Respir Res. 2020;21(1):53.
[2] ALSALEEM M, MALIK A, LAKSHMINRUSIMHA S, et al. Hydrocortisone Improves Oxygenation Index and Systolic Blood Pressure in Term Infants With Persistent Pulmonary Hypertension. Clin Med Insights Pediatr. 2019;13:1179556519888918.
[3] NG QX, VENKATANARAYANAN N, HO CYX, et al. Selective Serotonin Reuptake Inhibitors and Persistent Pulmonary Hypertension of the Newborn: An Update Meta-Analysis.J Womens Health (Larchmt). 2019;28(3):331-338.
[4] MATHEW R. Signaling Pathways Involved in the Development of Bronchopulmonary Dysplasia and Pulmonary Hypertension. Children (Basel). 2020;7(8):100.
[5] MATHEW R. Cell-Specific Dual Role of Caveolin-1 in Pulmonary Hypertension.Pulm Med. 2011;2011:573432.
[6] 王萌萌, 李贺, 张方方, 等. 钙敏感受体在新生小鼠持续性肺动脉高压中的作用[J]. 中国当代儿科杂志,2017,19(2):208-214.
[7] 李翔, 吴冰霞, 李贺, 等. 钙敏感受体对持续性肺动脉高压新生小鼠内皮型一氧化氮合酶及一氧化氮的影响[J]. 中国当代儿科杂志,2019,21(2):189-194.
[8] AMBALAVANAN N, BULGER A, MURPHY-ULLRICH J, et al. Endothelin-A receptor blockade prevents and partially reverses neonatal hypoxic pulmonary vascular remodeling. Pediatr Res. 2005;57(5):631-636.
[9] ZHIWEN C, XIANG L, BINGXIA W, et al. Effects of calcium-sensitive receptors on 11β-hydroxysteroid dehydrogenase type 2 and cortisol in neonatal mice with persistent pulmonary hypertension. Zhongguo Dang Dai Er Ke Za Zhi. 2019; 21(11):1124-1130.
[10] COONEY TP, THURLBECK WM. The radial alveolar count method of emery and mithal: a reappraisal 1-postnatal lung growth. Thorax. 1982;37(8):572-579.
[11] Knudsen L, Weibel ER, Gundersen HJ, et al. Assessment of air space size characteristics by intercept (chord) measurement: An accurate and efficient stereological approach. J Appl Physiol (1985). 2010;108(2):412-421.
[12] Steinhorn RH. Diagnosis and treatment of pulmonary hypertension in infancy. Early Hum Dev. 2013;89(11):865-874.
[13] Smith KA, Yuan JX. Hypoxia-Inducible factor-lα in pulmonary arterial smooth muscle cells and hypoxia-induced pulmonary hypertension. Am J Respir Crit Care Med.2014;189(3): 245-246.
[14] Moreno J, Escobedo D, Calhoun C, et al. Arterial Wall Stiffening in Caveolin-1 Deficiency-Induced Pulmonary Artery Hypertension in Mice. Exp Mech. 2021;6(1):217-228.
[15] Xu XF, Gu WZ, Wu XL, et al. Fetal pulmonary vascular remodeling in a rat model induced by hypoxia and indomethacin. J Matern Fetal Neonatal Med. 2011;24(1):172-182.
[16] Chen M, Ding Z, Zhang F, et al. A20 attenuates hypoxia-induced pulmonary arterial hypertension by inhibiting NF-kB activation and pulmonary artery smooth muscle cell proliferation. Exp Cell Res. 2020;390(2):111982.
[17] MATHEW R. Pathogenesis of pulmonary hypertension:a case for caveolin-1 and cell membrane integrity. Am J Physiol Heart Circ Physiol. 2014;306(1):H15-H25.
[18] SCHRECKENBERG R, SCHLÜTER KD.Calcium sensing receptor expression and signalling in cardiovascular physiology and disease. Vascul Pharmacol. 2018: S1537-1891(17)30323.
[19] YAMAMURA A, YAGI S, OHARA N, et al. Calcilytics enhance sildenafil-induced antiproliferation in idiopathic pulmonary arterial hypertension. Eur J Pharmacol. 2016;784:15-21.
[20] TILLU VA, RAE J, GAO Y,et al. Cavin1 intrinsically disordered domains are essential for fuzzy electrostatic interactions and caveola formation. Nat Commun. 2021;12(1):931.
[21] MARSHALL JD, BAZAN I, ZHANG Y, et al. Mitochondrial dysfunction and pulmonary hypertension: cause, effect, or both. Am J Physiol Lung Cell Mol Physiol. 2018; 314(5):L782-L796.
[22] OLIVEIRA SDS, MINSHALL RD. Caveolin and Endothelial NO Signaling.Curr Top Membr. 2018;82:257-279.
[23] CHEN Z, BAKHSHI FR, SHAJAHAN AN, et al. Nitric oxide-dependent Src activation and resultant caveolin-1 phosphorylation promote eNOS/caveolin-1 binding and eNOS inhibition. Mol Biol Cell. 2012;23(7):1388-1398.
[24] FURONG Y, LILI S, XIAOYANG C, et al. Molecular regulation and clinical significance of caveolin-1 methylation in chronic lung diseases. Clin Transl Med. 2020;10(1):151-160.
[25] SAMARAKOON R, CHITNIS SS, HIGGINS SP, et al. Redox-induced Src kinase and caveolin-1 signaling in TGF-β1-initiated SMAD2/3 activation and PAI-1 expression.PLoS One. 2011;6(7):e22896.